Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Radiation Therapy With Anti-PD-1 Antibody in Treating Patients With Unresectable Pancreatic Cancer

NCT03374293 is registered in ClinicalTrials.gov with Shixiu Wu as lead sponsor.

NCT NCT03374293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03374293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Radiation Therapy With Anti-PD-1 Antibody in Treating Patients With Unresectable Pancreatic Cancer
Lead sponsor
Shixiu Wu
Phase
Phase 2
Overall status
Unknown status
Start date
December 1, 2017
Completion date
December 31, 2021
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer